PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY ... [Ann N Y Acad Sci. 1965] - PubMed

Save items

loading

Related citations in PubMed

[PRELIMINARY FINDINGS ON THE USE OF SYNTHETIC ACTH IN THE THERAPY OF MULTIPLE SCLEROSIS]. [Minerva Med. 1964]
[PRELIMINARY FINDINGS ON THE USE OF SYNTHETIC ACTH IN THE THERAPY OF MULTIPLE SCLEROSIS].
CAZZULLO CL, LUBAN B, MONTANINI R. Minerva Med. 1964 Nov 17; 55:3651-6.
Review Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice. [Curr Opin Neurol. 2007]
Review Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice.
Costello F, Stüve O, Weber MS, Zamvil SS, Frohman E. Curr Opin Neurol. 2007 Jun; 20(3):281-5.
USE OF AN ORAL CORTICOSTEROID IN THE TREATMENT OF MULTIPLE SCLEROSIS; A DOUBLE-BLIND STUDY. [Arch Neurol. 1965]
USE OF AN ORAL CORTICOSTEROID IN THE TREATMENT OF MULTIPLE SCLEROSIS; A DOUBLE-BLIND STUDY.
TOURTELLOTTE WW, HAERER AF. Arch Neurol. 1965 May; 12:536-45.
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL. [Ann N Y Acad Sci. 1965]
QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL.
TOURTELLOTTE WW, HAERER AF, SIMPSON JF, KUZMA JW, SIKORSKI J. Ann N Y Acad Sci. 1965 Mar 31; 122:480-505.
Setting the agenda for multiple sclerosis rehabilitation research. [Mult Scler. 2008]
Setting the agenda for multiple sclerosis rehabilitation research.
Kraft GH, Johnson KL, Yorkston K, Amtmann D, Bamer A, Bombardier C, Ehde D, Fraser R, Starks H. Mult Scler. 2008 Nov; 14(9):1292-7. Epub 2008 Jul 16.

See reviews... See all...

Cited by 88 PubMed Central articles

Predictors of attack severity and duration in multiple sclerosis: a prospective study. [Open Neurol J. 2011]
Predictors of attack severity and duration in multiple sclerosis: a prospective study.
Naldi P, Collimedaglia L, Vecchio D, Rosso MG, Perl F, Stecco A, Monaco F, Leone MA. Open Neurol J. 2011; 5:75-82. Epub 2011 Dec 23.
Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America. [Ther Adv Neurol Disord. 2011]
Optimizing outcomes in multiple sclerosis: consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America.
Carrá A, Macías-Islas MÁ, Gabbai AA, Correale J, Bolaña C, Sotelo ED, Bonitto JG, Vergara-Edwards F, Vizcarra-Escobar D. Ther Adv Neurol Disord. 2011 Nov; 4(6):349-60.
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. [Ann Neurol. 2011]
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, et al. Ann Neurol. 2011 Feb; 69(2):292-302.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE ...
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.
Ann N Y Acad Sci. 1965 Mar 31 ;122:552-68.

PubMed
Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alp...
Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha).
J Invest Dermatol. 1992 Nov ;99(5):48S-50S.

PubMed
A NEW HAEMOGLOBIN, D IBADAN (BETA-87 THREONINE -- LYSINE), PRODUCING NO SICKLE-C...
A NEW HAEMOGLOBIN, D IBADAN (BETA-87 THREONINE -- LYSINE), PRODUCING NO SICKLE-CELL HAEMOGLOBIN D DISEASE WITH HAEMOGLOBIN S.
Nature. 1965 Mar 27 ;205:1273-6.

PubMed
The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex.
The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex.
J Immunol. 1992 Dec 1 ;149(11):3695-701.

PubMed
The anti-anxiety and anti-agitation effects of paroxetine in depressed patients.
The anti-anxiety and anti-agitation effects of paroxetine in depressed patients.
Int Clin Psychopharmacol. 1992 Jun ;6 Suppl 4:81-90.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

MeSH Terms

MeSH Terms

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 88 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information